Search results
Camzyos and cost: Reducing long-term drug costs and more
Medical News Today· 2 days agoThe cost of the drug with and without insurance can depend on several factors, such as whether...
Earnings call: Amylyx reports a net loss of $118.8 million
Investing.com· 6 days agoAmylyx Pharmaceuticals Inc. (AMLX) discussed its first-quarter 2024 financial results and provided...
What will DEA rescheduling mean for cannabis in Alabama? Experts weigh in. - Birmingham Business...
The Business Journals· 14 hours agoLast month the U.S. Department of Drug Enforcement Administration announced plans to reclassify...
SHP report claims hospitals overcharging for oncology drugs
Winston-Salem Journal· 6 days agoThe program, known as 340B, was created by Congress in 1992 to financially assist hospitals serving...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
WHTC 1450 Holland· 5 days ago(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of medications...
TONI SAYS: Please simplify Medicare’s enrollment process
Odessa American· 2 hours agoMy friends are advising me if I do not sign up for Medicare when I turn 65, I will be making a major Medicare mistake. Can you please simplify the Medicare enrollment process? Medicare is exploding ...
Anthem vs. Blue Cross Blue Shield: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 24 hours agoAnthem is a BCBS company, but its numbers fall below the BCBS collective average.
MediPharm Labs Reports First Quarter Results
FOX 4 Kansas City· 4 hours agoMediPharm is optimistic about recent Associated Press reports that the US Drug Enforcement Agency ("US DEA") will move cannabis from a Schedule I to a...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Reuters· 5 days agoAbout one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows By Reuters
Investing.com· 5 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...
